echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chengdu Better Pharmaceutical's Ampicillin Sodium for Injection has been successfully evaluated

    Chengdu Better Pharmaceutical's Ampicillin Sodium for Injection has been successfully evaluated

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 22, the official website of the State Food and Drug Administration showed that Chengdu Better Pharmaceutical's Ampicillin Sodium for injection successfully passed the evaluation, and it was the first in China; in addition, the company recently imitated the 4 types of dabigatran etexilate capsules.


    Will win $1.


    Source: official website of the State Food and Drug Administration

    Dabigatran etexilate belongs to the β-alanine thrombin inhibitor, which is converted into dabigatran with direct anticoagulant activity in the body after oral absorption through the gastrointestinal tract.


    The original research product was approved to enter the domestic market as early as February 2013.


    Sales of Dabigatran Etexilate Capsules in Entity Pharmacies in Chinese Cities (Unit: RMB million)

    Source: Mi Nei.


    In recent years, the sales of dabigatran etexilate in physical pharmacies in Chinese cities have increased year by year.


    In addition to the original manufacturers, there are currently two domestic companies, Zhengda Tianqing and Hausen, that have approvals for the production of dabigatran etexilate capsules.


    Chengdu Better Pharmaceutical Co.


    Source: Meinenet MED2.


    According to data from Minai.


    The first review of ampicillin sodium for injection

    Ampicillin sodium is a broad-spectrum semi-synthetic penicillin, suitable for respiratory infections, gastrointestinal infections, urinary tract infections, soft tissue infections, endocarditis, meningitis, sepsis, etc.


    At present, there are more than 30 domestic companies with approvals for the production of ampicillin sodium for injection.


    Consistency Evaluation and Application Status of Ampicillin Sodium for Injection

    Source: Mi Nei Net Consistency Evaluation Database

    Two companies, Chengdu Better Pharmaceuticals and Harbin Pharmaceutical Group Pharmaceutical General Factory, submitted supplementary applications for the consistency evaluation of ampicillin sodium for injection.


    Source: Minei.


    Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.